*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Cost-benefit Analysis of Clinical Preventive Services: Perspective of Pharmacists in Tertiary Hospitals in South-Eastern Nigeria

Author: ANOSIKE, CHIBUEZE*, ADIBE. MAXWELL OGOCHUKWU, IGBOELI, NNEKA UCHENNA
Abstract: Aim: This study aimed to conduct a cost-benefit analysis of hospital pharmacists provided clinical preventive services in tertiary hospitals in South-Eastern Nigeria. Methods: A cross-sectional study was conducted among out-patients in two tertiary hospitals. Using contingent valuation, we elicited respondents’ willingness to pay (WTP) for pharmacists provided clinical preventive services (CPS). The cost of providing CPS was calculated from the perspective of pharmacists. Benefit-cost ratio (BCR) and price elasticity of demand for CPS were calculated. Descriptive statistics was used to present patients’ sociodemographic characteristics. The predictors of WTP and WTP amount for CPS was modelled using multivariate regression. P values < 0.05 were considered statistically significant. Results: Of the 466 participants, about 71% of the respondents were willing to pay an average of US$0.85 ± 1.16 for CPS. BCR for CPS was 2.38 (95% CI 2.25-6.99). Price elasticity of demand for CPS was inelastic. Patients with self-reported “average health status” had 66.7% higher WTP odds for CPS than those with “good health status.” Every unit increase in monthly income led to US$0.27 increase in WTP amount for CPS. Conclusion: Our findings showed high patient acceptance of CPS, as a substantial proportion were willing to pay for the service. Pharmacists provided CPS was cost-beneficial as every dollar spent returns about US$2.4 for the service providers. However, income level and health status were major contributors of patients’ WTP for the service.
Keyword: Clinical preventive service, hospital pharmacists, cost-benefit analysis, contingent valuations
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free